
Keywords: HNSCC, head and neck squamous cell carcinoma; TIVA, total intravenous anesthesia; MAC, minimum alveolar concentration; NSAID, nonsteroidal anti-inflammatory drug; HIF-1α, hypoxia inducible factor 1 alpha; HIF-2α, hypoxia inducible factor 2 alpha; SIRT1, s